Adherence to Clinical Guidelines for Fibromyalgia: Help or Hindrance?

References

• Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ open. 2023;13(1):e062158. doi:10.1136/bmjopen-2022-062158.
   PubMed Web of Science ®Google Scholar
• Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep. 2004;8(5):369–3. doi:10.1007/s11916-996-0010-6.
   PubMedGoogle Scholar
• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. doi:10.1007/s11916-013-0356-5.
   PubMed Web of Science ®Google Scholar
• Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, Choy E, Kosek E, Amris K, Branco J, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017;76(2):318–28. doi:10.1136/annrheumdis-2016-209724.
   PubMed Web of Science ®Google Scholar
• Fitzcharles M-A, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin D, Panopalis P, Proulx J, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome. [accessed 2013 May 20]. http://www.canadianpainsociety.ca/pdf/Fibromyalgia_Guidelines_2012.pdf.
   Google Scholar
• Sommer C, Alten R, Bär KJ, Bernateck M, Brückle W, Friedel E, Henningsen P, Petzke F, Tölle T, Üçeyler N, et al. Drug therapy of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Schmerz (Berlin, Germany). 2017;31(3):274–84. doi:10.1007/s00482-017-0207-0.
   PubMed Web of Science ®Google Scholar
• De Clifford-Faugère G, Nguena Nguefack H, Godbout-Parent M, Diallo M, Guénette L, Pagé G, Choiniere M, Beaudoin S, Boulanger A, Pinard A, et al. Pain medications used by persons living with fibromyalgia: a comparison between the profile of a Quebec sample and clinical practice guidelines. Can J Pain. 2023. doi:10.1080/24740527.2023.2252037.
   Google Scholar
• Gendelman O, Shapira R, Tiosano S, Kuntzman Y, Tsur AM, Hakimian A, Comaneshter D, Cohen AD, Buskila D, Amital H. Utilisation of healthcare services and drug consumption in fibromyalgia: a cross-sectional analysis of the Clalit Health Service database. Int J Clin Pract. 2021;75(11):e14729. doi:10.1111/ijcp.14729.
   PubMed Web of Science ®Google Scholar
• Ben-Ami Shor D, Weitzman D, Dahan S, Gendelman O, Bar-On Y, Amital D, Shalev V, Chodick G, Adherence AH. Persistence with drug therapy among fibromyalgia patients: data from a large health maintenance organization. J Rheumatol. 2017;44(10):1499–506. doi:10.3899/jrheum.170098.
   PubMed Web of Science ®Google Scholar
• Ministère de la Santé et des Services Sociaux. Algorithme de prise en charge de la fibromyalgie. 2021. https://publications.msss.gouv.qc.ca/msss/fichiers/2021/21-947-03W.pdf.
   Google Scholar
• Margolis JM, Princic N, Smith DM, Abraham L, Cappelleri JC, Shah SN, Park PW. Economic impact of adherence to pain treatment guidelines in chronic pain patients. Pain Med. 2019;20(10):1907–18. doi:10.1093/pm/pnz085.
   PubMed Web of Science ®Google Scholar
• Robinson RL, Kroenke K, Mease P, Williams DA, Chen Y, D’Souza D, Wohlreich M, McCarberg B. Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med 2012;13(10):1366–76. doi:10.1111/j.1526-4637.2012.01475.x.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen SY, Wu N, Fraser KA, Boulanger L. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine. Pain Pract. 2011;11(4):381–91. doi:10.1111/j.1533-2500.2010.00431.x.
   PubMed Web of Science ®Google Scholar
• Lage-Hansen PR, Chrysidis S, Amris K, Fredslund-Andersen S, Christensen R, Ellingsen T. Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic. Scand J Rheumatol. 2022:1–10. doi:10.1080/03009742.2022.2145703.
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Faregh N, Ste-Marie PA, Shir Y. Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study. Pain Res Treat. 2013;2013:898493. doi:10.1155/2013/898493.
   PubMedGoogle Scholar
• Robinson RL, Kroenke K, Williams DA, Mease P, Chen Y, Faries D, Peng X, Hann D, Wohlreich M, McCarberg B. Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study. Pain Med. 2013;14(9):1400–15. doi:10.1111/pme.12168.
   PubMed Web of Science ®Google Scholar
• Desai R, Jo A, Marlow NM. Risk for medication nonadherence among medicaid enrollees with Fibromyalgia: development of a validated risk prediction tool. Pain Pract. 2019;19(3):295–302. doi:10.1111/papr.12743.
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Dobkin PL, Bernatsky S, Baron M, Starr M, Cohen M, Fitzcharles MA. Medication non-adherence in women with fibromyalgia. Rheumatology (Oxford). 2004;43(5):648–54. doi:10.1093/rheumatology/keh141.
   PubMed Web of Science ®Google Scholar